|
|
|
Volumn 15, Issue 1, 1997, Pages 13-19
|
|
Estramustine-based chemotherapy
|
|
Author keywords
antimitotic agents; Estramustine; hormone refractory prostate cancer; paclitaxel
|
|
Indexed keywords
ESTRAMUSTINE;
ETOPOSIDE;
IRINOTECAN;
PACLITAXEL;
TOPOTECAN;
VINBLASTINE;
BONE MARROW SUPPRESSION;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
DEEP VEIN THROMBOSIS;
DRUG EFFICACY;
EDEMA;
FATIGUE;
GYNECOMASTIA;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
NEUROTOXICITY;
ORAL DRUG ADMINISTRATION;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROSTATE CANCER;
REVIEW;
THROMBOCYTOPENIA;
ANTINEOPLASTIC AGENTS, HORMONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CLINICAL TRIALS;
DRUG SCREENING ASSAYS, ANTITUMOR;
ESTRAMUSTINE;
HUMANS;
MALE;
NEOPLASMS, HORMONE-DEPENDENT;
PROSTATIC NEOPLASMS;
|
|
EID: 0031042208
PISSN: 10810943
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (62)
|
|
References (47)
|